Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bergmann

Showing results (541-550 of 606) with videos related to

Pageof 61
Sort By:
The Journal of Clinical Endocrinology and Metabolism|November 2, 2020
Identification and Metabolic Profiling of a Novel Human Gut-derived LEAP2 FragmentChristoffer A Hagemann, Chen Zhang, Henrik H Hansen, et al.
Allergy|May 13, 2014
Geographic and temporal variations in pollen exposure across EuropeM Smith, S Jäger, U Berger, et al.
Rheumatology (Oxford, England)|July 22, 2024
Preventive effects of early immunosuppressive treatment on the development of interstitial lung disease in systemic sclerosisA Velauthapillai, M F R Bootsma, C Bruni, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|September 9, 2017
Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis controlD Caimmi, N Baiz, L K Tanno, et al.
Laryngo- Rhino- Otologie|August 29, 2020
L Klimek, A G Beule, U Förster-Ruhrmann, et al.
Clinical and Translational Allergy|July 23, 2020
AllergoOncology: ultra-low IgE, a potential novel biomarker in cancer-a Position Paper of the European Academy of Allergy and Clinical Immunology (EAACI)D Ferastraoaru, H J Bax, C Bergmann, et al.
Plos Pathogens|February 4, 2017
Early endonuclease-mediated evasion of RNA sensing ensures efficient coronavirus replicationEveline Kindler, Cristina Gil-Cruz, Julia Spanier, et al.
Laryngo- Rhino- Otologie|February 15, 2022
L Klimek, H Olze, U Förster-Ruhrmann, et al.
Pneumologie (Stuttgart, Germany)|November 10, 2016
[Medical Diagnostics for Mold Exposure Indoors]G A Wiesmüller, B Heinzow, U Aurbach, et al.
Allergy|April 19, 2011
How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statementJean Bousquet, H J Schünemann, P J Bousquet, et al.
Pageof 61

Showing results (541-550 of 606) with videos related to

Sort By:
Pageof 61
The Journal of Clinical Endocrinology and Metabolism|November 2, 2020
Identification and Metabolic Profiling of a Novel Human Gut-derived LEAP2 FragmentChristoffer A Hagemann, Chen Zhang, Henrik H Hansen, et al.
Allergy|May 13, 2014
Geographic and temporal variations in pollen exposure across EuropeM Smith, S Jäger, U Berger, et al.
Rheumatology (Oxford, England)|July 22, 2024
Preventive effects of early immunosuppressive treatment on the development of interstitial lung disease in systemic sclerosisA Velauthapillai, M F R Bootsma, C Bruni, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|September 9, 2017
Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis controlD Caimmi, N Baiz, L K Tanno, et al.
Laryngo- Rhino- Otologie|August 29, 2020
L Klimek, A G Beule, U Förster-Ruhrmann, et al.
Clinical and Translational Allergy|July 23, 2020
AllergoOncology: ultra-low IgE, a potential novel biomarker in cancer-a Position Paper of the European Academy of Allergy and Clinical Immunology (EAACI)D Ferastraoaru, H J Bax, C Bergmann, et al.
Plos Pathogens|February 4, 2017
Early endonuclease-mediated evasion of RNA sensing ensures efficient coronavirus replicationEveline Kindler, Cristina Gil-Cruz, Julia Spanier, et al.
Laryngo- Rhino- Otologie|February 15, 2022
L Klimek, H Olze, U Förster-Ruhrmann, et al.
Pneumologie (Stuttgart, Germany)|November 10, 2016
[Medical Diagnostics for Mold Exposure Indoors]G A Wiesmüller, B Heinzow, U Aurbach, et al.
Allergy|April 19, 2011
How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statementJean Bousquet, H J Schünemann, P J Bousquet, et al.
Pageof 61